AlphAIalphai — Financial news for AI agents
benzinga.comJUL 313 min read$RYAN

These Analysts Boost Their Forecasts On Ryan Specialty After Better-Than-Expected Q2 Earnings - Ryan Spec

Ryan Specialty Holdings (NYSE:RYAN) reported Q2 earnings of 74 cents per share, above the 60 cents consensus, and sales of $916.647 million versus $872.957 million expected. Shares rose 11.7% to $49.25 pre-market. After the results, Barclays raised its price target to $48 and Keefe, Bruyette & Woods to $54, both maintaining positive ratings.

Original reporting
benzinga.com
Published Jul 31, 2026, 1:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 2:43 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$RYAN
Bullish
medium confidence
Mentioned
$RYAN
Relevance
8/10
alphai data visualization · based on benzinga.com
Decision brief

The 30-second read

$RYANBullishMed
01

Why it matters

The combination of a Q2 beat, a sizable premarket jump, and two raised price targets can drive short-term momentum and additional estimate revisions.

02

Market read

Traders get a concrete earnings beat with quantified EPS and revenue, plus immediate analyst target increases that can extend the post-earnings repricing.

03

What to watch

Analyst target changes are secondary to the earnings print; without management guidance, traders may overestimate durability of the move.

Relevance 8/10Novelty 6/10Timing: pre-market today after Q2 earnings release

Background

Ryan Specialty is an insurance specialty brokerage firm; the article frames results as delivered despite a challenging environment.

Company-level read

Ticker impact

$RYANBullishMedium confidence
Context

Ryan Specialty reported Q2 EPS of 74 cents and sales of $916.647M, beating consensus, and shares jumped 11.7% premarket.

Expected impact

Likely supports continued momentum and upward revisions, though follow-through depends on guidance not provided here.

Evidence & confidence

The article provides hard Q2 beat figures, a large premarket move, and two specific price-target increases (Barclays and KBW) tied to the earnings release.

Market effects

Sector

Positive read-through for insurance brokerage/wholesale insurance intermediaries if results signal resilience in a challenging environment.

Regional

Primarily US-focused sentiment given NYSE-listed issuer and premarket reaction.

Global

Limited, as the disclosure is company-specific and not tied to global macro or cross-border transactions.

Counterpoint

What could challenge this read

The article highlights the beat and target raises but does not include guidance or margin details, so the market may fade if forward expectations are unchanged.

Key entities

  • company
    Ryan Specialty Holdings Inc

    Reported better-than-expected Q2 earnings and saw shares rise 11.7% premarket.

  • analyst_firm
    Barclays

    Raised Ryan Specialty price target from $46 to $48, maintained Overweight.

  • analyst_firm
    Keefe, Bruyette & Woods

    Boosted Ryan Specialty price target from $48 to $54, maintained Outperform.

Read at source← All news

Related articles

JUL 31
$RYANMedAI 8/10

Ryan Specialty posts Q2 revenue gain as E&S market slows

Ryan Specialty Holdings, Inc. reported second-quarter 2026 net commissions and fees of $902.7 million, up 7.4% year-over-year. Total revenue for the quarter reached $916.6 million, a 7.2% increase from $855.2 million a year earlier. Organic revenue growth came in at 6.7%, down from 7.1% in the prior-year period. The deceleration continues a trend across multiple quarters as the broader E&S market moderates.

insurancebusinessmag.com6 min
JUL 30
$RYANMed

RYAN SPECIALTY HOLDINGS, INC. (RYAN): Results of Operations and Financial Condition

RYAN SPECIALTY HOLDINGS, INC. (RYAN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ryan-20260630xex991.htm EX-99.1 RYAN-2026.06.30-EX 99.1 1 RYAN SPECIALTY REPORTS SECOND QUARTER 2026 RESULTS - Total Revenue grew 7.2% year-over-year to $916.6 million - - Organic Revenue Growth Rate* of 6.7% year-over-year - - Net Income of $108.4 million , or $0.33 pe

SEC EDGAR 8-K6 min
AUG 8
$KDMed

Kyndryl Q1 Earnings Call Highlights

Kyndryl (NYSE:KD) Q1 call said demand is rising for AI deployment, hybrid modernization, cybersecurity and data-residency. It reported 40 deals worth over $50M in 12 months, with 10 in Q1, and Kyndryl Consult signings up 50%. IBM relationship changes are expected to weigh on constant-currency revenue through FY2027. FCF was -$401M; cash $2.1B. Outlook FY2027 reaffirmed.

yahoo.com5 min
AUG 8
$KAIMedAI 8/10

Kadant Q2 Earnings Call Highlights

Kadant (NYSE:KAI) reported Q2 equipment backlog of $182 million and said aftermarket demand stayed at record or near-record levels. Flow Control revenue rose 5% to $100 million; Industrial Processing revenue rose to a record $144 million; Material Handling bookings were $73 million. Q2 gross margin fell to 43.8%. Kadant raised FY revenue guidance to $1.19-$1.21B and adjusted EPS to $12.43-$12.68.

yahoo.com6 min
AUG 8
$KRPMed

Kimbell Royalty Q2 Earnings Call Highlights

Kimbell Royalty (NYSE:KRP) reported record Q2 adjusted EBITDA of $84.9 million, with cash G&A of $5.9 million ($2.50 per BOE). It declared a $0.47 per common unit cash distribution, up 15% QoQ, and said 47% may be return of capital. The borrowing base rose to $660 million; debt was $478.7 million. Rig activity and production varied by basin.

yahoo.com6 min